COMMUNIQUÉS West-GlobeNewswire

BioSyent Schedules Q4 2018 Earnings Release for March 20, 2019
15/03/2019
TORONTO, March 15, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and twelve months ended December 31, 2018 on Wednesday, March [...]
Matrix Medical Network to Present at RISE Nashville Summit 2019
15/03/2019
SCOTTSDALE, Ariz., March 15, 2019 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix) engages with health plan members wherever they are in their journey to health improvement, delivering healthcare services in homes [...]
Lexicon Pharmaceuticals Announces Dosing of First Patient in TELE-ABC Study, a Phase 2a Clinical Study of Telotristat Ethyl in Biliary Tract Cancer
15/03/2019
THE WOODLANDS, Texas, March 15, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today dosing of the first patient in the Tel otristat E thyl for A dvanced B iliary Tract C ancer, or TELE [...]
Canada House Oversubscribed in its Unit Financing
15/03/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 15, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”) is [...]
Sienna Announces March Dividend
15/03/2019
MARKHAM, Ontario, March 15, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.0765 per common share of the Company (each, a “Common Share”) [...]
Sales of Olainfarm Continue Growing in February
15/03/2019
Consolidated sales – February and 2 months Preliminary consolidated results of JSC Olainfarm for February 2019, show that the Group has made sales worth 11.4 million euros, which represents an increase by 7% compared to [...]
BBS-Bioactive Bone Substitutes Plc: Correction to the invitation to annual general meeting of BBS-Bioactive Bone Substitutes Plc published on 15.03.2019 at 12:00 CET
15/03/2019
Correction to the invitation to annual general meeting of BBS-Bioactive Bone Substitutes Plc published on 15.03.2019 at 12:00 CET Participation also requests the shareholder to be temporarily entered into the [...]
Diamond CBD to Showcase Exciting New Product Lines at ASD Market Week
15/03/2019
Popularity of the Company's CBD-infused edibles, oils, and vapes continues to surge ahead of influential Las Vegas trade show for consumer merchandise FT. LAUDERDALE, Fla., March 15, 2019 (GLOBE NEWSWIRE) -- Diamond CBD [...]
Yield10 Bioscience Announces Pricing of $2.9 Million Registered Direct Offering
15/03/2019
WOBURN, Mass., March 15, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today [...]
Vilacto Bio Canada Patent LACTOACTIVE® Granted
15/03/2019
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB:VIBI) is happy to announce that the Canadian Intellectual Property Office (CIPO) has informed the Company that its patent application [...]
Outlook Therapeutics Announces Reverse Stock Split
15/03/2019
CRANBURY, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”) announced today that its Board of Directors has approved a 1-for-8 reverse stock split of the Company’s common [...]
Helix TCS Expands into Global Markets -- CFN Media
15/03/2019
Seattle, WA, March 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019
15/03/2019
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
15/03/2019
PRINCETON, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced that an abstract presenting data from two Phase 1 in vivo wear studies on the [...]
Innovation Pharmaceuticals Requesting European Medicines Agency (EMA) Input for International Phase 3 Brilacidin Oral Mucositis Program
15/03/2019
BEVERLY, Mass., March 15, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that necessary documentation has [...]
Matrix Medical Network showcases state-of-the-art mobile health clinic at RISE Nashville
15/03/2019
Summit highlights company’s national fleet providing an inside look at the future of population health SCOTTSDALE, Ariz., March 15, 2019 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix) builds upon last year’s mobile [...]
Selecta Biosciences Announces Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update
15/03/2019
Phase 2 head-to-head (COMPARE) clinical trial of SEL-212 vs. KRYSTEXXA® to begin in 1Q19, interim six-month data expected in 4Q19 Collaboration with CureCN projected to dose first patient with combination of ImmTOR + [...]
Extendicare Announces March 2019 Dividend of C$0.04 per Share
15/03/2019
MARKHAM, Ontario, March 15, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial Results
15/03/2019
LIVONIA, Mich., March 15, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of [...]

Pages